2019 annual financial data
Anika Therapeutics 2019 Operating margin
Direct answer
Operating margin was 29.88%.
Operating income was 34,248,000 USD and net income was 27,193,000 USD.
Operating cash flow was 37,005,000 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 114,610,000 USD
- Operating income
- 34,248,000 USD
- Net income
- 27,193,000 USD
- Operating cash flow
- 37,005,000 USD